Wespac Advisors So Cal, LLC Edwards Lifesciences Corp Transaction History

Wespac Advisors So Cal, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$71.69 - $91.23 $215,070 - $273,690	-3,000 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$57.54 - $76.95 $115,080 - $153,900	2,000 Added 200.0%	3,000 $203,000
Q1 2020 Apr 30, 2020	BUY	$52.41 - $81.0 $52,410 - $81,000	1,000 New	1,000 $228,000
Q3 2019 Oct 17, 2019	SELL	$61.55 - $75.43 $89,555 - $109,750	-1,455 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$55.74 - $64.41 $16,220 - $18,743	-291 Reduced 16.67%	1,455 $268,000
Q1 2019 May 02, 2019	BUY	$47.89 - $64.05 $1,005 - $1,345	21 Added 1.22%	1,746 $334,000
Q3 2018 Oct 22, 2018	SELL	$45.7 - $58.03 $5,712 - $7,253	-125 Reduced 6.76%	1,725 $300,000
Q2 2018 Aug 03, 2018	SELL	$42.45 - $51.3 $1,061 - $1,282	-25 Reduced 1.33%	1,850 $269,000
Q3 2017 Nov 03, 2017	SELL	$36.29 - $38.83 $907 - $970	-25 Reduced 1.32%	1,875 $204,000
Q2 2017 Aug 11, 2017	BUY	N/A	1,900	1,900 $224,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.